recombinant murine ifnβ (MedChemExpress)
Structured Review

Recombinant Murine Ifnβ, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 322 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant murine ifnβ/product/MedChemExpress
Average 96 stars, based on 322 article reviews
Images
1) Product Images from "Cytosolic nucleic acid sensing triggers type I interferon activation via the Hippo kinase LATS1"
Article Title: Cytosolic nucleic acid sensing triggers type I interferon activation via the Hippo kinase LATS1
Journal: The Journal of Biological Chemistry
doi: 10.1016/j.jbc.2026.111204
Figure Legend Snippet: Pharmacological Inhibition of LATS impedes cytosolic nucleic acid sensing PRR activation of IFN-I. A , immunoblot analysis ( left panel ) and relative quantification ( right panel ) of IRF3 (S396) phosphorylation in MEF cells pretreated with vehicle control (DMSO) or LATS inhibitor (20 μM; 2.5 h) then transfected with pI:C or ISD (2 μg/ml each; 3 h). B , qPCR analysis of Ifnb mRNA in MEF cells pretreated with DMSO or LATS inhibitor as in A , followed by pI:C transfection (2 μg/ml; 3.5 h) ( left panel ) or ISD transfection (2 μg/ml; 4 h) ( right panel ). C and D , qPCR of Cxcl10, Ccl5, and Isg15 mRNA in MEF cells pretreated with DMSO or LATS1 inhibitor followed by pI:C transfection as in B , left panel ( C ) or ISD as in B , right panel ( D ). Statistical significance was determined using student’s t test (∗∗∗ p < 0.001, ∗∗ p < 0.01, and ∗ p < 0.05).
Techniques Used: Inhibition, Activation Assay, Western Blot, Quantitative Proteomics, Phospho-proteomics, Control, Transfection
Figure Legend Snippet: LATS1 is required for IFN-I activation. A and B , qPCR analysis of Ifnb mRNA expression in WT and Lats1 −/− MEF cells infected with VSV (MOI 0.5) ( A ) or HSV-1 (MOI 0.1) for 24 h. C and D , qPCR analysis of Cxcl10 and Ccl5 mRNA in WT and Lats1 −/− MEF cells infected with VSV as in panel A ( C ) or HSV-1 as in panel B ( D ). E and F , immunoblot analysis ( left panels ) and relative quantification ( right panels ) of IRF3 (S396) phosphorylation in WT and Lats1 −/− MEF cells transfected with pI:C ( E ) or ISD ( F ) (2 μg/ml each) for the indicated times. G and H , qPCR analysis of Ifnb mRNA expression in WT and Lats1 −/− MEF cells transfected with pI:C ( G ) or ISD ( H ) (2 μg/ml each) for the indicated times. I and J , ELISA for IFN-β secretion in WT and Lats1 −/− MEF cells transfected with pI:C ( I ) or ISD ( J ) (2 μg/ml each; 6 h). K and L , qPCR analysis of Cxcl10, Ccl5, and Isg15 mRNA in WT and Lats1 −/− MEF cells transfected with pI:C ( K ) or ISD ( L ) (2 μg/ml each) for the indicated times. Statistical significance was determined using Student’s t test (∗∗∗ p < 0.001, ∗∗ p < 0.01, and ∗ p < 0.05).
Techniques Used: Activation Assay, Expressing, Infection, Western Blot, Quantitative Proteomics, Phospho-proteomics, Transfection, Enzyme-linked Immunosorbent Assay
Figure Legend Snippet: LATS1 operates at the level of TBK1. A , immunoblot analysis of LATS1 expression in HEK 293T cells treated with control siRNA or siRNAs targeting LATS1 for 24 h. B , IFN-β luciferase reporter assay in HEK 293T cells treated with control siRNA or siRNAs targeting LATS1 as in A , followed by transfection of plasmids encoding RIG-I, MAVS, STING, TBK1, and IRF3. C , co-immunoprecipitation and immunoblot of FLAG-LATS1 and HA-TBK1 co-transfected in HEK 293T cells. D and E , immunoblot analysis of TBK1-LATS1 interactions in MEF cells transfected with pI:C ( D ) or ISD ( E ) (2.5 μg/ml each; 2 h). Statistical significance was determined using student’s t test (∗∗∗ p < 0.001, ∗∗ p < 0.01, and ∗ p < 0.05).
Techniques Used: Western Blot, Expressing, Control, Luciferase, Reporter Assay, Transfection, Immunoprecipitation
Figure Legend Snippet: LATS1 facilitates TBK1 activation and signaling events. A and B , immunoblot analysis ( left panels ) and relative quantification ( right panels ) of TBK1 (S172) phosphorylation in WT and Lats1 −/− MEF cells transfected with pI:C ( A ) or ISD ( B ) (2 μg/ml each) for the indicated times. C , immunoblot analysis of TBK1 (S172) phosphorylation in HEK 293T cells co-transfected with plasmids encoding WT TBK1 or kinase dead (KD) TBK1 (K38A) in the absence or presence of LATS1. D , IFN-β luciferase reporter assay in HEK 293T cells co-transfected with plasmids encoding TBK1 in the presence of WT LATS1 or kinase dead (KD) LATS1 (D846A). E , co-immunoprecipitation and immunoblot ( left panel ) and relative quantification ( right panel ) of WT LATS1-TBK1 and KD LATS1-TBK1 interactions in HEK 293T cells co-transfected with the indicated plasmids. F , co-immunoprecipitation and immunoblot ( left panel ) and relative quantification ( right panel ) of TBK1-IRF3 interactions in the absence or presence of LATS1 in HEK 293T cells co-transfected with the indicated plasmids. G and H , immunoblot analysis of TBK1-IRF3 interactions in WT and Lats1 −/− MEF cells transfected with pI:C ( G ) or ISD ( H ) (2 μg/ml each; 2.5 h). Statistical significance was determined using student’s t test (∗∗∗ p < 0.001, ∗∗ p < 0.01, and ∗ p < 0.05).
Techniques Used: Activation Assay, Western Blot, Quantitative Proteomics, Phospho-proteomics, Transfection, Luciferase, Reporter Assay, Immunoprecipitation
Figure Legend Snippet: Model of Hippo kinase LATS1-dependent regulation of IFN-I in cytosolic nucleic acid sensing PRR signaling pathways. Under basal conditions, YAP operates as a steady-state negative regulator of TBK1-IRF3 signaling in part by associating with TBK1. Upon the detection of RNA or DNA virus genomes by distinct cytosolic PRRs, the Hippo kinase LATS1 undergoes phosphorylation to trigger the phospho-inhibition of YAP, abrogating its ability to antagonize TBK1. Activated LATS1 further associates with TBK1 and licenses TBK1 dependent signaling to IRF3, resulting in the subsequent induction of IFN-I. Figure created with BioRender.
Techniques Used: Protein-Protein interactions, Virus, Phospho-proteomics, Inhibition

